These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32255703)

  • 1. The impact of crowdsourcing in modern drug discovery.
    Schuhmacher A; Kuss M
    Expert Opin Drug Discov; 2020 Aug; 15(8):865-867. PubMed ID: 32255703
    [No Abstract]   [Full Text] [Related]  

  • 2. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowdsourcing in pharmaceutical R&D: a revolutionary concept or nothing new?
    Song CH
    Pharm Pat Anal; 2016 Sep; 5(6):355-360. PubMed ID: 27804785
    [No Abstract]   [Full Text] [Related]  

  • 4. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crowd sourcing in drug discovery.
    Lessl M; Bryans JS; Richards D; Asadullah K
    Nat Rev Drug Discov; 2011 Apr; 10(4):241-2. PubMed ID: 21455221
    [No Abstract]   [Full Text] [Related]  

  • 7. Crowdsourcing and open innovation in drug discovery: recent contributions and future directions.
    Thompson DC; Bentzien J
    Drug Discov Today; 2020 Dec; 25(12):2284-2293. PubMed ID: 33011343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 11. News & Analysis: new initiative aims to improve success of early stage drug discovery.
    Coaker H
    Future Med Chem; 2014 May; 6(7):733. PubMed ID: 24941869
    [No Abstract]   [Full Text] [Related]  

  • 12. An open source pharma roadmap.
    Balasegaram M; Kolb P; McKew J; Menon J; Olliaro P; Sablinski T; Thomas Z; Todd MH; Torreele E; Wilbanks J
    PLoS Med; 2017 Apr; 14(4):e1002276. PubMed ID: 28419094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-centered drug discovery as the means to improved R&D productivity.
    Raoof AA; Aerssens J
    Drug Discov Today; 2015 Sep; 20(9):1044-8. PubMed ID: 25908579
    [No Abstract]   [Full Text] [Related]  

  • 14. Creativity, innovation and lean sigma: a controversial combination?
    Johnstone C; Pairaudeau G; Pettersson JA
    Drug Discov Today; 2011 Jan; 16(1-2):50-7. PubMed ID: 21094693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving models of collaborative drug discovery: managing intellectual capital assets.
    Allarakhia M
    Expert Opin Drug Discov; 2018 Jun; 13(6):473-476. PubMed ID: 29569503
    [No Abstract]   [Full Text] [Related]  

  • 17. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D.
    Schuhmacher A; Brieke C; Gassmann O; Hinder M; Hartl D
    Drug Discov Today; 2021 Dec; 26(12):2786-2793. PubMed ID: 34229082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery.
    Wood J; Sames L; Moore A; Ekins S
    Drug Discov Today; 2013 Nov; 18(21-22):1043-51. PubMed ID: 23968993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
    Forster SP; Stegmaier J; Spycher R; Seeger S
    Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.